First Time Loading...

Centessa Pharmaceuticals PLC
NASDAQ:CNTA

Watchlist Manager
Centessa Pharmaceuticals PLC Logo
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Watchlist
Price: 9.47 USD -0.84% Market Closed
Updated: May 5, 2024

Centessa Pharmaceuticals PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Centessa Pharmaceuticals PLC
Cash from Operating Activities Peer Comparison

Comparables:
EXAI
AUTL
BCYC
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Cash from Operating Activities
-£117.6m
CAGR 3-Years
-62%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$60.6m
CAGR 3-Years
-5%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
£2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
£44.6m
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is Centessa Pharmaceuticals PLC's Cash from Operating Activities?
Cash from Operating Activities
-160.3m USD

Based on the financial report for Dec 31, 2023, Centessa Pharmaceuticals PLC's Cash from Operating Activities amounts to -160.3m USD.

What is Centessa Pharmaceuticals PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-147%

Over the last year, the Cash from Operating Activities growth was 20%. The average annual Cash from Operating Activities growth rates for Centessa Pharmaceuticals PLC have been -147% over the past three years .